Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir | Zendy

Hervé Jacquier | Zendy; Gauthier Péan de Ponfilly | Zendy; Anthony Chauvin | Zendy; Rishma Amarsy | Zendy; Hana Benmansour | Zendy; Dan-Thanh Hoang-Nguyen | Zendy; Emmanuel Lecorché | Zendy; Céline Mesnil | Zendy; Faïza Mougari | Zendy; AnneLise Munier | Zendy; Maud Salmona | Zendy; Béatrice Berçot | Zendy; Jérôme Le Goff | Zendy; Emmanuelle Cambau | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir

Author(s) -

Hervé Jacquier,

Gauthier Péan de Ponfilly,

Anthony Chauvin,

Rishma Amarsy,

Hana Benmansour,

Dan-Thanh Hoang-Nguyen,

Emmanuel Lecorché,

Céline Mesnil,

Faïza Mougari,

AnneLise Munier,

Maud Salmona,

Béatrice Berçot,

Jérôme Le Goff,

Emmanuelle Cambau

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa374

Subject(s) - oseltamivir , medicine , medical prescription , virology , emergency medicine , pharmacology , covid-19 , disease , infectious disease (medical specialty)

We assessed the impact of a rapid molecular assay for influenza detection whether outsourced or performed onsite 24/7 in a University Hospital in Paris, France. Shorter median time-to-results (16.8 vs 2.3 hours, P < .05) and an increased rate of adequate prescription of oseltamivir (76.6% vs 95.3%, P < .05) were observed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research